These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2252755)

  • 21. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):216-8, 253. PubMed ID: 8194433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
    Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-lowering effects of lovastatin in CAPD patients.
    Jacobs RH; Lal SM; Nolph KD
    Adv Perit Dial; 1993; 9():288-90. PubMed ID: 8105945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin and markers of endothelial function in patients undergoing continuous ambulatory peritoneal dialysis.
    Malyszko J; Malyszko JS; Hryszko T; Brzosko S; Mysliwiec M
    Int J Tissue React; 2002; 24(3):111-5. PubMed ID: 12635864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN
    Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment].
    Fiorini F; Patrone E; Ardu F; Castelluccio A
    Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
    Antonicelli R; Onorato G; Pagelli P; Pierazzoli L; Paciaroni E
    Clin Ther; 1990; 12(2):165-71. PubMed ID: 2354486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
    Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastain affects TAFI and thrombomodulin in CAPD patients.
    Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
    Thromb Haemost; 2001 Sep; 86(3):930-1. PubMed ID: 11583330
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A; Novo S; Notarbartolo A; Davì G; Abrignani MG; Alaimo G; Averna MR; Barbagallo CM; Marino G
    Cardiologia; 1989 Dec; 34(12):1027-33. PubMed ID: 2634479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dyslipidemia in the uremic patient: the therapeutic role played by simvastatin].
    Bellinghieri G; Angelé B; Savica V
    Clin Ter; 1992 Jan; 140(1 Pt 2):11-6. PubMed ID: 1559316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A; Stancáková A; Javorský M; Tkác I
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
    Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
    Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dislipemia in patients undergoing continuous ambulatory peritoneal dialysis: pharmacological therapy (simvastatin) versus hemodialysis.
    Marangoni R; Civardi F; Masi F; Cimino R; Maltagliati L; Romei Longhena G
    Perit Dial Int; 1993; 13 Suppl 2():S431-3. PubMed ID: 8399632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F; Patrone E; Castelluccio A
    Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.